An original musical holiday greeting from SAFE-BioPharma shows Santa addressing identity management and document management issues using the SAFE-BioPharma® digital identity and signature standard. The greeting is now available at http://www.safe-biopharma.org/holiday.
The SAFE-BioPharma digital identity and signature standard is used across the biopharmaceutical industry to manage digital identities and to apply digital signatures to electronic documents. Its use reduces paper, improves processes and reduces costs.
The 60-second musical greeting can be at viewed at http://www.safe-biopharma.org/holiday and in the LinkedIn SAFE-BioPharma group http://www.linkedin.com/groups?home=&gid=1946679&trk=anet_ug_hm.
About SAFE-BioPharma Association (www.safe-biopharma.org) SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.
The Association’s members include:
- Abbott (NYSE: ABT)
- Amarin Corp. (NASDAQ: AMRN)
- Amgen (NASDAQ: AMGN)
- AstraZeneca (NYSE: AZN)
- Bristol-Myers Squibb (NYSE: BMY)
- GlaxoSmithKline (NYSE: GSK)
- Johnson & Johnson (NYSE: JNJ)
- Eli Lilly (NYSE: LLY)
- McDougall Scientific
- Merck (NYSE: MRK)
- National Notary Association
- Novartis (NYSE: NVS)
- Oxford Outcomes
- Pfizer (NYSE: PFE)
- Premier Inc.
- Roche
- Sanofi-Aventis (NYSE: SNY)
- ScheringPlough-Organon (NYSE: SGP)
- SNAP Diagnostics
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.
Contacts:
Jon Weisberg
M 801-860-9977
O
801-359-9977
Jon.weisberg@safe-biopharma.org
